Mostrar el registro sencillo

dc.contributor.advisorLópez Hoyos, Marcos 
dc.contributor.advisorIrure Ventura, Juan
dc.contributor.authorAlonso Fernández-Martos, Cristina
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-09-23T06:53:04Z
dc.date.issued2022-05-31
dc.identifier.urihttps://hdl.handle.net/10902/25936
dc.description.abstractThis dissertation is based on the comparative analysis of the different elements of the immune response (both innate and adaptative), triggered against SARS-CoV-2 after natural infection and after vaccination. Such analysis is based on two cohorts studied at the Hospital Universitario Marqués de Valdecilla. To this end, the main epidemiological characteristics, immunological parameters and in-hospital evolution of 155 COVID-19 positive patients were first analysed. The patients were divided into two groups (mild and moderate-severe), according to their oxygen therapy requirements at admission. Moreover, the immune response of 52 healthcare professionals after being vaccinated with a double dose of the BNT162b2 Pfizer-BioNTech vaccine was also analysed. On the one hand, it was observed that patients classified as moderate-severe were noted to be older and had significantly higher levels of ferritin, D-dimer, C-reactive protein, troponin, IL-6, neutrophils and depleted CD8 T lymphocytes, as well as lymphopenia and reduced levels of Th1 lymphocytes and Treg cells. Conversely, patients classified in the mild group had significantly higher levels of non-classical monocytes, innate lymphoid cells and NK cells in peripheral blood. Furthermore, those classified as moderate-severe required more chronic treatment on admission and were more often treated in-hospital. On the other hand, regarding the vaccinated group of healthcare workers, an increase in memory Th1 helper lymphocytes, peripheral follicular T helper memory cells and memory B lymphocytes with isotype change was observed after the administration of the second dose of the vaccine. There was also evidence of an activation of the immune system by means of a specific anti-S T response.es_ES
dc.format.extent43 p.es_ES
dc.language.isospaes_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subject.otherSARS-CoV2es_ES
dc.subject.otherRespuesta inmunitaria innataes_ES
dc.subject.otherRespuesta inmunitaria adquiridaes_ES
dc.subject.otherCOVID-19es_ES
dc.subject.otherBNT162bes_ES
dc.subject.otherInnate immune responsees_ES
dc.subject.otherAdaptative immune responsees_ES
dc.titleRespuesta inmunitaria frente a SARS CoV-2 tras infección natural y tras vacunaciónes_ES
dc.title.alternativeImmune response to SARS CoV-2 after natural infection and after vaccinationes_ES
dc.typeinfo:eu-repo/semantics/bachelorThesises_ES
dc.rights.accessRightsopenAccesses_ES
dc.description.degreeGrado en Medicinaes_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Atribución-NoComercial-SinDerivadas 3.0 EspañaExcepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España